Compare CTSO & GORO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CTSO | GORO |
|---|---|---|
| Founded | 1997 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Precious Metals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 45.9M | 112.3M |
| IPO Year | N/A | N/A |
| Metric | CTSO | GORO |
|---|---|---|
| Price | $0.72 | $0.73 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 2 |
| Target Price | ★ $5.38 | $1.38 |
| AVG Volume (30 Days) | 126.1K | ★ 1.1M |
| Earning Date | 11-13-2025 | 11-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $36,979,520.00 | ★ $61,430,000.00 |
| Revenue This Year | $9.51 | $8.76 |
| Revenue Next Year | $24.40 | $85.95 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 23.89 | N/A |
| 52 Week Low | $0.60 | $0.16 |
| 52 Week High | $1.61 | $1.18 |
| Indicator | CTSO | GORO |
|---|---|---|
| Relative Strength Index (RSI) | 47.96 | 50.66 |
| Support Level | $0.70 | $0.71 |
| Resistance Level | $0.75 | $0.80 |
| Average True Range (ATR) | 0.07 | 0.05 |
| MACD | 0.01 | 0.01 |
| Stochastic Oscillator | 56.00 | 55.23 |
CytoSorbents Corp specializes in treating life-threatening conditions in intensive care and cardiac surgery using proprietary polymer adsorption technology. Its flagship product, CytoSorb, is approved in the EU as an extracorporeal cytokine absorber, aiming to reduce inflammation and prevent multiple organ failure in critical illnesses like sepsis and trauma. Revenue primarily comes from product sales in Germany, with additional income from grant agencies in the United States. The company operates through Direct sales and Distributors/strategic partners in United States, Germany and Other Countries. The company's product consists of Cytosorb, ECOS-300CY, VetResQ, HemoDefend, and DrugSorb-ATR.
Gold Resource Corp is a producer of metal concentrates that contain gold, silver, copper, lead, and zinc in Oaxaca, Mexico. . It targets low capital expenditure projects with the potential for generating high returns on capital. The company's two pipeline projects are; Don David Gold at Oaxaca, Mexico, and Back Forty at Michigan, United States of America. The Company has two reporting segments, based on geographic regions. Oaxaca, Mexico represents the Company's only operating segment with a production stage property. The Company's other reporting segment is Michigan, U.S.A., with an exploration stage property.